Kuros Biosciences signed a private label agreement to supply bone graft material to SeaSpine, which will market the products as OsteoCurrent in the U.S. and select ex-U.S. markets.
SpinalCyte was issued a new patent in Canada, related to subjecting fibroblast cells to specific environments to differentiate into chondrocytes for use in joints and spinal discs.
Study results indicate that FH Orthopedics' LP-ESP® Lumbar Prosthesis demonstrated excellent midterm follow-up results in total disc replacement at five years.